GO:0036467 5-hydroxy-L-tryptophan decarboxylase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0036467 describes the enzymatic activity that converts 5-hydroxy-L-tryptophan (5-HTP) into serotonin (5-HT) with release of CO2.
• This activity is a key step in serotonin biosynthesis and is attributed to aromatic L-amino acid decarboxylase (AADC, DDC) in mammals.
• In vivo PET studies using labeled 5-HTP allow measurement of this decarboxylase activity in the brain and peripheral tissues.
• Substrate specificity can be engineered in related tryptophan decarboxylases, showing that the active site tolerates modifications.
• 5-HTP loading alters serotonin signaling and can modify behaviors such as amphetamine-induced locomotor activation in rodents.
• The activity is relevant to neuroendocrine tumors, where serotonin production and PET imaging of amine precursors are used diagnostically.
Description
GO:0036467, 5-hydroxy-L-tryptophan decarboxylase activity, is a molecular function defined as the catalysis of the reaction: 5-hydroxy-L-tryptophan + H+ = CO2 + serotonin. This activity is central to the biosynthesis of serotonin (5-hydroxytryptamine, 5-HT), a monoamine neurotransmitter and peripheral signaling molecule. In mammals, the decarboxylation of 5-hydroxy-L-tryptophan (5-HTP) is carried out by aromatic L-amino acid decarboxylase (AADC, encoded by DDC), which also decarboxylates L-dopa in dopamine synthesis. The reaction is pyridoxal phosphate-dependent and represents the final step in the serotonin biosynthetic pathway from tryptophan. Researchers study this activity to understand serotonin production in the brain, gut, and neuroendocrine tissues, and to develop imaging probes and pharmacological tools. Because serotonin dysregulation is implicated in mood, movement, and tumor biology, measuring and manipulating 5-hydroxy-L-tryptophan decarboxylase activity is of broad biomedical interest.
5-hydroxy-L-tryptophan decarboxylase activity At A Glance
| GO ID | GO:0036467 |
|---|---|
| GO term | 5-hydroxy-L-tryptophan decarboxylase activity |
| Ontology | molecular_function |
| Synonym | 5-hydroxytryptophan decarboxylase activity |
| Major function | Catalysis of 5-hydroxy-L-tryptophan decarboxylation to serotonin and CO2 |
| Reaction | 5-hydroxy-L-tryptophan + H+ = CO2 + serotonin |
| Cofactor | Pyridoxal phosphate (PLP) dependent (typical of aromatic amino acid decarboxylases) |
| Related enzyme | Aromatic L-amino acid decarboxylase (AADC, DDC) |
| Pathway context | Serotonin biosynthesis |
What Is GO:0036467?
In simple terms, GO:0036467 is the enzyme activity that removes a carboxyl group from 5-hydroxy-L-tryptophan to produce serotonin. The official definition is: Catalysis of the reaction: 5-hydroxy-L-tryptophan + H+ = CO2 + serotonin. This activity is synonymous with 5-hydroxytryptophan decarboxylase activity and is classified under the molecular_function aspect of the Gene Ontology.
Why Is 5-hydroxy-L-tryptophan decarboxylase activity Important in Cell Biology?
5-hydroxy-L-tryptophan decarboxylase activity is the terminal enzymatic step in serotonin production, making it a critical control point for serotonergic signaling. In the brain, serotonin regulates mood, sleep, appetite, and motor activity, and alterations in its synthesis are linked to neurological and psychiatric conditions. In the periphery, serotonin produced by enterochromaffin cells and neuroendocrine tumors influences gastrointestinal motility and tumor imaging. The activity is also a target for PET tracers that measure decarboxylase capacity in vivo, providing a functional readout of serotonin synthesis in health and disease. Understanding this activity helps researchers interpret pharmacological effects of 5-HTP loading and design enzyme inhibitors or substrate analogs.
• It is the final step in serotonin biosynthesis, converting 5-HTP to serotonin.
• It is mediated by aromatic L-amino acid decarboxylase (AADC/DDC), a PLP-dependent enzyme.
• PET imaging with labeled 5-HTP enables non-invasive measurement of decarboxylase activity in the brain.
• Altered serotonin production is relevant to neuroendocrine tumors and gastrointestinal function.
• 5-HTP administration can modify behavioral responses to psychostimulants in animal models.
• Substrate analogs and active-site engineering can modulate decarboxylase specificity.
• The activity is a potential biomarker for serotonergic dysfunction in neurological disorders.
• It provides a target for developing enzyme inhibitors or prodrugs affecting serotonin levels.
• Measuring this activity helps interpret the effects of L-dopa and 5-HTP therapies.
• It is a model system for studying PLP-dependent decarboxylation mechanisms.
What Happens During 5-hydroxy-L-tryptophan decarboxylase activity?
Substrate binding and cofactor interaction
In simple terms: The enzyme grabs 5-HTP and uses a vitamin B6-derived helper to start the reaction.
The reaction begins with binding of 5-hydroxy-L-tryptophan to the active site of aromatic L-amino acid decarboxylase (AADC). This enzyme uses pyridoxal phosphate (PLP) as a cofactor, which forms a Schiff base with the substrate amino group. Studies on related decarboxylases show that active-site residues determine substrate specificity and catalytic efficiency.
Decarboxylation and serotonin formation
In simple terms: The enzyme removes a carboxyl group from 5-HTP, releasing CO2 and leaving serotonin.
Following Schiff base formation, decarboxylation occurs, releasing carbon dioxide and generating serotonin. This step is the defining catalytic event of GO:0036467. In vivo PET studies using labeled 5-HTP confirm that this decarboxylation occurs in the brain and can be quantified as a measure of AADC activity.
Product release and serotonin availability
In simple terms: Serotonin is released and becomes available for signaling or storage.
After decarboxylation, serotonin is released from the enzyme and can be packaged into vesicles or degraded. The rate of this activity influences serotonin levels in the brain and periphery. Chronic administration of 5-HTP or L-dopa can alter decarboxylase activity in vivo, as shown in animal studies.
Physiological context of the reaction
In simple terms: This reaction happens in specific cells that make serotonin, such as neurons and enterochromaffin cells.
5-hydroxy-L-tryptophan decarboxylase activity is prominent in serotonergic neurons, enterochromaffin cells of the gut, and neuroendocrine tumors. PET imaging with 5-HTP analogs is used to visualize these tissues, reflecting decarboxylase activity in vivo. In the gut, increased cholinergic activity evoked by 5-HTP suggests that peripheral serotonin synthesis can influence gastrointestinal motility.
Key Genes Involved in GO:0036467 5-hydroxy-L-tryptophan decarboxylase activity
The following genes and proteins are directly or indirectly associated with 5-hydroxy-L-tryptophan decarboxylase activity, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DDC (AADC) | Encodes aromatic L-amino acid decarboxylase, the enzyme catalyzing 5-HTP decarboxylation | Central to serotonin and dopamine synthesis; target for PET imaging and pharmacological studies |
| TPH1 | Tryptophan hydroxylase 1, rate-limiting enzyme in peripheral serotonin synthesis | Provides substrate for AADC in enterochromaffin cells; relevant to gut serotonin |
| TPH2 | Tryptophan hydroxylase 2, rate-limiting enzyme in neuronal serotonin synthesis | Neuronal 5-HTP supply for AADC; linked to mood and behavior |
| SLC6A4 | Serotonin transporter | Regulates serotonin reuptake; indirect readout of serotonin production |
| HTR1A | Serotonin receptor 1A | Mediates serotonergic signaling; downstream of serotonin synthesis |
| HTR2A | Serotonin receptor 2A | Mediates serotonergic signaling in brain and periphery |
| SLC7A5 | L-type amino acid transporter | Transports 5-HTP and tryptophan analogs; used in PET imaging |
| SLC3A2 | Amino acid transporter heavy chain | Partners with SLC7A5 for transport of aromatic amino acids |
| GAD1 | Glutamate decarboxylase 1 | Related PLP-dependent decarboxylase; comparative studies |
| GAD2 | Glutamate decarboxylase 2 | Related PLP-dependent decarboxylase; comparative studies |
| CsTDC | Basidiomycete tryptophan decarboxylase | Model for active-site engineering of substrate specificity |
| TPH | Tryptophan hydroxylase (general) | Upstream enzyme providing 5-HTP for decarboxylation |
| MAOA | Monoamine oxidase A | Degrades serotonin; balances serotonin levels |
| MAOB | Monoamine oxidase B | Degrades serotonin and dopamine; relevant to monoamine turnover |
| COMT | Catechol-O-methyltransferase | Metabolizes monoamines; indirect effect on serotonin |
| DDC paralogs | Other aromatic amino acid decarboxylases | Comparative enzymology and evolution |
| PLP-binding proteins | Pyridoxal phosphate-dependent enzymes | Cofactor supply and mechanism |
How Is 5-hydroxy-L-tryptophan decarboxylase activity Regulated?
The activity of 5-hydroxy-L-tryptophan decarboxylase is regulated at multiple levels. Enzyme abundance and cofactor availability (pyridoxal phosphate) influence reaction rate. Chronic administration of L-dopa or 5-HTP can alter decarboxylase activity in the brain, as shown in feline models. Substrate availability from tryptophan hydroxylase (TPH1/TPH2) is a major upstream control point. Additionally, transport of 5-HTP into cells via amino acid transporters such as SLC7A5/SLC3A2 affects substrate access. Pharmacological agents and substrate analogs can inhibit or modulate the enzyme, as demonstrated with fluoromethyl tryptophan analogues.
5-hydroxy-L-tryptophan decarboxylase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DDC | AADC deficiency; serotonin/dopamine imbalance | Knockout or point-mutation cell models to assess enzyme activity |
| TPH1 | Gastrointestinal motility disorders | Overexpression or knockout in enterochromaffin cell lines |
| TPH2 | Mood disorders; serotonergic dysfunction | Neuronal knockout or knock-in models |
| SLC7A5 | Tumor imaging; amino acid transport | Knockout cells for PET tracer uptake studies |
| MAOA | Aggression; monoamine metabolism | Overexpression or knockout models |
Neuroendocrine tumors and serotonin production
Neuroendocrine tumors often overproduce serotonin, and PET imaging with amine precursors such as 5-HTP is used to diagnose and monitor these tumors. The decarboxylase activity measured by PET reflects tumor serotonin synthesis. This makes GO:0036467 a relevant functional marker in oncology.
Neurological and psychiatric disorders
Alterations in serotonin synthesis have been implicated in mood disorders, movement disorders, and behavioral conditions. 5-HTP loading studies in rodents show that increasing substrate for decarboxylation can modify locomotor responses to amphetamine, suggesting a role in psychostimulant effects. PET studies of AADC activity in the brain provide a window into serotonergic function in vivo.
Gastrointestinal function
Peripheral serotonin produced via this activity influences gastrointestinal motility. In rats, 5-HTP administration increased gastric cholinergic activity, linking decarboxylase activity to gut function. This has implications for understanding irritable bowel syndrome and other motility disorders.
From 5-hydroxy-L-tryptophan decarboxylase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of DDC abolish 5-HTP decarboxylation? | DDC knockout cell line (e.g., neuroblastoma or enterochromaffin cells) |
| Does a point mutation alter substrate specificity? | Point-mutation knock-in of DDC active-site residues |
| Can tagged DDC be used for localization studies? | Knock-in of fluorescent or epitope tag at DDC locus |
| Does overexpression increase serotonin production? | DDC overexpression in serotonergic cell models |
| Is SLC7A5 required for 5-HTP uptake? | SLC7A5 knockout cells followed by 5-HTP loading |
| Does TPH1/TPH2 modulation affect downstream decarboxylation? | TPH1 or TPH2 knockout/overexpression models |
How to Study the 5-hydroxy-L-tryptophan decarboxylase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| HPLC with electrochemical detection | Serotonin and 5-HTP levels | Enzyme activity in tissue homogenates |
| Mass spectrometry | Serotonin production | Kinetic assays and inhibitor screening |
| PET with 18F-5-HTP | Decarboxylase activity in vivo | Brain and tumor imaging |
| RNA-seq | DDC and pathway gene expression | Transcriptomic profiling after genetic manipulation |
| Western blot | AADC protein levels | Validation of knockout or overexpression |
| Behavioral tracking | Locomotor activity | Assessing serotonin-related phenotypes |
| Gastric motility assay | Cholinergic activity | Peripheral serotonin effects |
| Site-directed mutagenesis | Enzyme kinetics and specificity | Active-site engineering |
Enzymatic activity assays
Direct measurement of 5-hydroxy-L-tryptophan decarboxylase activity can be performed using radiolabeled or fluorescent substrates, detecting serotonin production by HPLC or mass spectrometry. Such assays are used to characterize enzyme kinetics and inhibitor effects.
PET imaging
Positron emission tomography with labeled 5-HTP or analogs allows non-invasive quantification of decarboxylase activity in vivo. This approach has been used in monkey brain and in neuroendocrine tumor diagnosis.
Genetic manipulation and expression analysis
Knockout, knockdown, or overexpression of DDC and related genes in cell lines or animal models can reveal the contribution of this activity to serotonin levels and downstream phenotypes. RNA-seq and proteomics can confirm expression changes.
Behavioral and physiological readouts
In animal models, 5-HTP loading followed by behavioral tests (e.g., locomotor activity) or physiological measurements (e.g., gastric cholinergic activity) can link decarboxylase activity to organism-level outcomes.
How CRISPR Can Be Used to Study GO:0036467 5-hydroxy-L-tryptophan decarboxylase activity
Knockout
CRISPR knockout of DDC can eliminate 5-hydroxy-L-tryptophan decarboxylase activity, allowing researchers to test its requirement for serotonin production and downstream phenotypes. Such models are useful for validating enzyme function in cell lines and organoids.
Point Mutation
Introducing point mutations in the DDC active site can alter substrate binding or catalytic efficiency, helping to dissect structure-function relationships. This approach mirrors active-site engineering studies in related decarboxylases.
Knock-in
Knock-in of tags or reporter genes at the DDC locus enables real-time tracking of enzyme expression and localization. This can be combined with PET tracer studies to correlate enzyme levels with activity.
Overexpression
Overexpression of DDC or related decarboxylases in cell models can increase serotonin production, providing a system to study downstream signaling and potential toxicity. This is particularly useful in neuroendocrine tumor models.
How EDITGENE Supports 5-hydroxy-L-tryptophan decarboxylase activity Research
Researchers studying 5-hydroxy-L-tryptophan decarboxylase activity-related genes often need to determine whether a candidate gene is causally involved in serotonin production, substrate specificity, or disease phenotypes. EDITGENE provides CRISPR-based cell model services to enable such functional studies with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for 5-hydroxy-L-tryptophan decarboxylase activity research.
Frequently Asked Questions About 5-hydroxy-L-tryptophan decarboxylase activity
What is 5-hydroxy-L-tryptophan decarboxylase activity?
It is the enzyme activity defined by GO:0036467 that converts 5-hydroxy-L-tryptophan to serotonin and carbon dioxide.
What genes are involved in 5-hydroxy-L-tryptophan decarboxylase activity?
The primary gene is DDC, which encodes aromatic L-amino acid decarboxylase (AADC). Other genes such as TPH1, TPH2, and SLC7A5 influence substrate supply and transport.
What is the reaction catalyzed by GO:0036467?
The reaction is: 5-hydroxy-L-tryptophan + H+ = CO2 + serotonin.
How is 5-hydroxy-L-tryptophan decarboxylase activity measured?
It can be measured by enzymatic assays detecting serotonin production, or by PET imaging with labeled 5-HTP in vivo.
Is 5-hydroxy-L-tryptophan decarboxylase activity the same as AADC activity?
AADC (aromatic L-amino acid decarboxylase) catalyzes this activity as part of its broader substrate range, which also includes L-dopa.
What diseases are associated with altered 5-hydroxy-L-tryptophan decarboxylase activity?
Neuroendocrine tumors, mood disorders, and gastrointestinal motility disorders have been linked to changes in serotonin synthesis.
Can CRISPR be used to study 5-hydroxy-L-tryptophan decarboxylase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can be used to manipulate DDC and related genes.
What cofactor is required for 5-hydroxy-L-tryptophan decarboxylase activity?
The enzyme is pyridoxal phosphate (PLP) dependent, like other aromatic amino acid decarboxylases.
How does 5-HTP loading affect behavior?
In rodents, 5-HTP loading can reduce amphetamine-induced locomotor activation, indicating effects on serotonergic signaling.
What is the role of 5-hydroxy-L-tryptophan decarboxylase activity in the gut?
It contributes to peripheral serotonin production, which can increase gastric cholinergic activity and influence motility.
Conclusion
GO:0036467, 5-hydroxy-L-tryptophan decarboxylase activity, is a fundamental enzymatic step in serotonin biosynthesis. Its study spans neurobiology, gastroenterology, and oncology, with tools ranging from enzymatic assays to PET imaging and CRISPR models. Understanding its regulation and genetic control can illuminate serotonin-related physiology and disease.
References
- 1. Sanger GJ et al.. 1986. Increased gastric cholinergic activity evoked by 5-hydroxy-L-tryptophan in the rat.. Eur J Pharmacol 127(3):179-85 PMID: 3019729
- 2. Hartvig P et al.. 1993. Positron emission tomographic studies on aromatic L-amino acid decarboxylase activity in vivo for L-dopa and 5-hydroxy-L-tryptophan in the monkey brain.. J Neural Transm Gen Sect 94(2):127-35 PMID: 8110439
- 3. Kalb D et al.. 2016. Active-Site Engineering Expands the Substrate Profile of the Basidiomycete L-Tryptophan Decarboxylase CsTDC.. Chembiochem 17(2):132-6 PMID: 26632772
- 4. Roberge AG et al.. 1974. Brain DOPA-5-HTP decarboxylase activity after the chronic administration of L-dopa or 5-hydroxy-L-tryptophan in normal and lesioned cats.. Brain Res 76(3):401-12 PMID: 4546739
- 5. Krämer SD et al.. 2012. 5-(2-18F-fluoroethoxy)-L-tryptophan as a substrate of system L transport for tumor imaging by PET.. J Nucl Med 53(3):434-42 PMID: 22331220
- 6. Sundin A et al.. 2004. PET in the diagnosis of neuroendocrine tumors.. Ann N Y Acad Sci 1014:246-57 PMID: 15153441
- 7. Zembower DE et al.. 1993. Enantiospecific syntheses of alpha-(fluoromethyl)tryptophan analogues: interactions with tryptophan hydroxylase and aromatic L-amino acid decarboxylase.. J Med Chem 36(3):305-13 PMID: 8426360
- 8. Baumann MH et al.. 2011. Serotonin (5-HT) precursor loading with 5-hydroxy-l-tryptophan (5-HTP) reduces locomotor activation produced by (+)-amphetamine in the rat.. Drug Alcohol Depend 114(2-3):147-52 PMID: 21071157
